Cipla Ltd shares rises under approval for Epzicom

Posted on

Cipla Oharma, Market Update, News UpdatePharma major Cipla Ltd rose 0.38% to Rs 594 at mid-noon on BSE after the company stated that it has obtained final approval for generic Epzicom tablets. The announcement was made on 4 April 2017, when the markets were shut on account of local holiday.
On the BSE, 1.08 lakh shares have been traded in the counter in the volatile trade, compared with the ADV (average daily volume) of 1.16 lakh shares in the past one quarter. The stock had hit a high and low of Rs 600.55 and  Rs 593.25 respectively during the day.
Cipla stock had underperformed the market over the past one month till 3 April 2017, gaining 0.71 % compared with 3.74% rise of Sensex. The scrip further underperformed the market in past one quarter, growing 3.07% as against 12.26% gain of Sensex.
The consolidated net profit of Cipla Ltd rose 43.85% to Rs. 374.83 Cr, on 15.64% rise in net sales to Rs, 3,550.02 crore in quarter third December 2016 Year-on-year.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s